KOREA PHARMA Co., Ltd. (KOSDAQ:032300)
South Korea · Delayed Price · Currency is KRW 13,520
+20 (0.15%)
Last updated: Oct 29, 2025, 2:06 PM KST
KOREA PHARMA Market Cap
KOREA PHARMA has a market cap or net worth of 144.3 billion as of October 31, 2025. Its market cap has decreased by -18.33% in one year.
Market Cap
144.30B
Enterprise Value
151.54B
Revenue
85.34B
Ranking
n/a
PE Ratio
99.71
Stock Price
13,520.00
Market Cap Chart
Since August 10, 2020, KOREA PHARMA's market cap has decreased from 183.78B to 144.30B, a decrease of -21.48%. That is a compound annual growth rate of -4.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 144.30B | -13.59% |
| Dec 30, 2024 | 166.98B | -35.26% |
| Dec 28, 2023 | 257.94B | 10.51% |
| Dec 29, 2022 | 233.40B | -55.92% |
| Dec 30, 2021 | 529.52B | 118.69% |
| Dec 30, 2020 | 242.13B | 31.75% |
| Aug 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 655.28T |
| SK hynix | 385.25T |
| LG Energy Solution | 120.28T |
| Samsung Biologics | 86.90T |
| Doosan Enerbility | 61.74T |
| Hyundai Motor Company | 56.31T |
| HD Hyundai Heavy Industries | 52.82T |
| Hanwha Aerospace | 51.09T |